NCT07778329 · ACTIVE NOT RECRUITING

Psychosocial Intervention for Behavioral Symptoms in Hospitalized Patients With Dementia or Delirium

This trial is testing whether adding a structured psychosocial program to standard drug treatment reduces behavioral symptoms like agitation, aggression, and sleep disturbances in hospitalized dementia or delirium patients over 65. The add-on includes personalized sensory stimulation sessions and caregiver education. It is a Phase NA randomized controlled trial, meaning it is evaluating a non-drug approach in a real clinical setting rather than testing a new drug for approval.

You may qualify if

  • Age older than 65 years.
  • Diagnosis of dementia and/or delirium.
  • Availability of a caregiver who also assists the participant at home and is willing to participate in the caregiver education program.
  • Presence of behavioral disturbances, defined as a Neuropsychiatric Inventory (NPI) total score of 24 or higher, or a score of 12 in at least one NPI symptom domain.
  • No clinical condition at hospital admission that would prevent delivery of the non-pharmacological intervention, including isolation for SARS-CoV-2 infection or another condition requiring isolation, deep sedation, coma, or severe respiratory failure.
  • Written informed consent provided by the participant, when capable of providing consent, or by the participant's legal guardian or legally authorized representative.
  • Written informed consent provided by the caregiver.

You're excluded if

  • Age younger than 65 years.
  • No diagnosis of dementia or delirium.
  • No available caregiver, or caregiver unwilling or unable to participate in the education program.
  • NPI total score lower than 24 and no individual NPI symptom domain score of 12.
  • Clinical condition present at admission or developing during hospitalization that prevents delivery of the non-pharmacological intervention, including isolation for SARS-CoV-2 infection or another condition requiring isolation, deep sedation, coma, or severe respiratory failure.
  • Informed consent not obtained from the participant, when capable of providing consent, or from the participant's legal guardian or legally authorized representative.
  • Informed consent not obtained from the caregiver.

The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.

Eligibility criteria as of 2026-08-21

View full record on ClinicalTrials.gov

All APOE4 clinical trials